Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Braz. J. Pharm. Sci. (Online) ; 58: e20205, 2022. tab, graf
Article in English | LILACS | ID: biblio-1403727

ABSTRACT

Abstract Several factors contribute to the resistance of some pathogenic microorganisms and this fact requires the search for new therapeutic alternatives. The genus Cyperus (family Cyperaceae) groups species that present chemical compounds of pharmacological interest, mainly with antimicrobial action. Thus, the present work was carried out to investigate the antimicrobial activities, antioxidants and the phytochemical profile of Cyperus articulatus L. and Cyperus iria L. Hydroalcoholic extracts (1:1, v:v) of the aerial and underground parts of these species were used to analyze the total phenol content and to evaluate the in vitro antioxidant activity against the DPPH (2,2-diphenyl-1-picrylhydrazyl). The ethyl acetate and chloroform phases resulting from liquid-liquid partitioning of C. articulatus and C. iria extracts were evaluated in antimicrobial assays and subject to high performance liquid chromatography (HPLC-DAD) analysis. The chromatograms obtained by HPLC-DAD allowed us to identify four compounds: chlorogenic acid, catechin, quercetin, and quercitrin. The hydroalcoholic extracts of C. articulatus and C. iria showed a weak antioxidant activity with IC50 of 395.57 and 321.33 µg/mL (aerial parts), and 1,114.01 and 436.82 µg/mL (underground parts), respectively. Regarding antimicrobial activity, the chloroform phase of C. iria showed the best result at the concentration of only 31.2 µg/mL against the pathogens Candida albicans and Staphylococcus aureus. The ethyl acetate phases of the aerial parts of C. articulatus and C. iria did not show antimicrobial activity


Subject(s)
Cyperaceae/classification , Cyperus/adverse effects , Phytochemicals , Anti-Infective Agents/analysis , Antioxidants/analysis , Plants, Medicinal/adverse effects , Candida albicans , Chromatography, High Pressure Liquid/methods , Inhibitory Concentration 50
2.
Rev. bras. farmacogn ; 27(2): 245-250, Mar.-Apr. 2017. tab, graf
Article in English | LILACS | ID: biblio-843798

ABSTRACT

ABSTRACT The increasing loss of local ecological knowledge may have negative impacts on the resilience of socio-ecological systems and may also negatively impact bioprospecting efforts, since local ecological knowledge is an important source of information for searching new drugs. Recent studies try to evaluate whether communities are experiencing loss of local ecological knowledge. However, some of them make conclusions which are erroneously based on specific analyses of a single indicator. We propose an integrative analysis of three indicators, namely: number of plants cited by young people and elders, therapeutic choices and people's connectance in terms of medicinal plant learning. The study was carried out in the community of Sucruiuzinho (Bahia, Brazil). We conducted semistructured interviews and a therapeutic recall with 24 local dwellers. We did not find evidence of local ecological knowledge loss in the studied community. Although younger people know fewer plants, they are well connected in terms of knowledge transmission. Moreover, in illness events, young people and adults have similar proportions of choice for plants when compared to allopathy. Concomitant use of the three indicators leads to a more realistic scenario of local ecological knowledge loss than the use of only one of them.

3.
Rev. bras. farmacogn ; 24(2): 110-115, Mar-Apr/2014.
Article in English | LILACS | ID: lil-714774

ABSTRACT

Ethnopharmacological and ethnobotanical approaches are described in the literature as efficient to identify plants of interest for phytochemical and pharmacological studies. In the present work, we reflect on the quality of the data collected in ethno-directed studies. In accordance to the problems identified in published studies, and their theoretical and methodological underpinnings, we believe that these studies are poorly suited to contribute to the advancement of research aimed at the development of novel drugs.

SELECTION OF CITATIONS
SEARCH DETAIL